Yungjin Pharm (Chae Joon Lee, CEO) held a groundbreaking ceremony for the construction of industrial complex in Yungjin Bio general industrial complex(45,177㎡), Hwaseong, Gyeonggi province on September 5, 2018.

At the event, they were joined by Jin Taek Oh (Congressman, Gyeonggi province), Heung Mo Sung (Manager, Hwaseong City Hall), Eong Ung Lee (Sungdo ENG, CEO), Ho Kyung Ann (Alt Plus S&D, CEO) including Yungjin Pharm CEO.

Yungjin Pharm needed the industrial complex for production capabilities to secure competitiveness in domestic and global markets. In the future, once the production facilities have been established in this industrial complexes, it will secure a global manufacturing competitiveness.

The CEO of Yungjin Pharm said "We will lead pharmaceutical and bio industries of Korea in the future through this construction of Yungjin Bio general industrial complex." and "It will also contribute by revitalizing the regional economy and creating local jobs."

Yungjin Pharm has focused on the continuous R&D efforts and sought growth globally through development of inovative new drugs since its establishment in 1952. Since 2010, Export has grown rapidly and it's one of the pharmaceutical companies with a high percentage of export in Korea.